Core Insights - Suzhou Pusi Imaging Medical has completed nearly 100 million RMB in Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Investment [1] - The company, founded in 2021, focuses on the research and industrialization of core components and complete systems for magnetic resonance imaging (MRI), utilizing innovative technologies to reduce reliance on liquid helium [1] - The founder, Dr. Ni Zhipeng, has a strong background in superconducting magnet research and has achieved breakthroughs in this field during his tenure at various prestigious institutions [1][2] Company Overview - Pusi Imaging Medical aims to develop domestically produced low-liquid-helium superconducting magnet technology to achieve a technological leap [2] - The proprietary PhaseXCool® technology developed by the company effectively transfers heat between the GM cold head and key components inside the magnet through the gas-liquid phase change of helium, ensuring stable operation of the magnet [2] - The company has completed three rounds of financing to date [3]